CliffBio
small molecule

COMBIVENT RESPIMAT

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Loss of exclusivityOctober 2030latest FDA-listed patent expiry
CompanyBoehringer Ingelheim →See this company's full patent-cliff portfolio

Drug detail

Brand nameCOMBIVENT RESPIMAT
Active ingredientALBUTEROL SULFATE; IPRATROPIUM BROMIDE
StrengthEQ 0.1MG BASE/INH;0.02MG/INH
Dosage formSPRAY, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalOctober 2011
Marketing statusRX

Listed patents

PatentExpiresType
8733341October 2030product
7837235March 2028product
9027967March 2027product
7396341October 2026product

More from Boehringer Ingelheim

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found